Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: a multicenter research network study

A Yousaf, S Gayam, S Feldman, Z Zinn… - Journal of the American …, 2021 - Elsevier
Background Data on the impact of biologics and immunomodulators on coronavirus disease
2019 (COVID-19)–related outcomes remain scarce. Objective We sought to determine …
被引用次数：60 相关文章

Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: a multicenter research network study.

A Yousaf, S Gayam, S Feldman, Z Zinn, M Kolodney - 2020 - cabidigitallibrary.org
Background: Data on the impact of biologics and immunomodulators on coronavirus
disease 2019 (COVID-19)-related outcomes remain scarce. Objective: We sought to …

[引用][C] Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study

A Yousaf, S Gayam, S Feldman, Z Zinn… - Journal of the American …, 2021 - cir.nii.ac.jp
Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or
methotrexate: A multicenter research network study | CiNii Research CiNii 国立情報学研究所 …
[HTML] nih.gov

[HTML][HTML] Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study

A Yousaf, S Gayam, S Feldman, Z Zinn… - Journal of the …, 2021 - ncbi.nlm.nih.gov
Background Data on the impact of biologics and immunomodulators on coronavirus disease
2019 (COVID-19)–related outcomes remain scarce. Objective We sought to determine …

Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study.

A Yousaf, S Gayam, S Feldman, Z Zinn… - Journal of the …, 2020 - europepmc.org
Background Data on the impact of biologics and immunomodulators on coronavirus disease
2019 (COVID-19)-related outcomes remain scarce. Objective We sought to determine …
[PDF] researchgate.net

[PDF][PDF] Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study

A Yousaf, S Gayam, S Feldman, Z Zinn - 2020 - researchgate.net
Background: Data on the impact of biologics and immunomodulators on coronavirus
disease 2019 (COVID-19) erelated outcomes remain scarce. Objective: We sought to …

Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study

A Yousaf, S Gayam, S Feldman, Z Zinn… - Journal of the American …, 2021 - jaad.org
Background Data on the impact of biologics and immunomodulators on coronavirus disease
2019 (COVID-19)–related outcomes remain scarce. Objective We sought to determine …

Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study

A Yousaf, S Gayam, S Feldman… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Data on the impact of biologics and immunomodulators on coronavirus disease
2019 (COVID-19)-related outcomes remain scarce. Objective We sought to determine …

Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study.

A Yousaf, S Gayam, S Feldman, Z Zinn… - Journal of the …, 2020 - europepmc.org
Background Data on the impact of biologics and immunomodulators on coronavirus disease
2019 (COVID-19)-related outcomes remain scarce. Objective We sought to determine …